Abstract: The present disclosure provides a method and apparatus for traffic management and control method, device and readable storage medium. The method includes: acquiring a data frame sent from a heterogeneous accelerator; selecting a target traffic management and control mode corresponding to data in the data frame from a plurality of preset traffic management and control modes; and managing and controlling the data in the data frame according to the target traffic management and control mode, so as to allocate the data to a QDMA queue, and send the data by the QDMA queue, and process the data by a corresponding CPU core.

Abstract: Disclosed are compounds suitable for enhancing cancer treatment, for example, a compound of formula (I): (I) wherein R1 is as defined herein. Also disclosed is a method of enhancing the response of cancer cells in a mammal to treatment with an apoptosis inducing ligand, a method of inducing apoptosis in cancer cells in a mammal, and a method of treating prostate cancer in mammal in need thereof comprising administration of a compound described herein.

Abstract: Provided is a wireless communication method, including: monitoring, by a device node, a wake-up frame using a monitoring duration at a first wake-up interval, wherein the wake-up frame is a wake-up frame that is continuously sent by a collection node; in response to that the device node has detected the wake-up frame, monitoring, by the device node, the wake-up frame using the monitoring duration at a second wake-up interval, wherein the first wake-up interval is greater than the second wake-up interval, and a duration of the wake-up frame is greater than the monitoring duration; and in response to that the device node fails to detect the wake-up frame within a preset duration when monitoring the wake-up frame at the second wake-up interval, entering, by the device node, a receiving state, so as to perform wireless communication between the collection node and the device node.

Abstract: A method and apparatus for performing a power stress test on an FPGA acceleration card and a computer-readable storage medium. The method includes: dividing, according to a partial reconfiguration method, a hardware resource of an FPGA acceleration card into a static region serving as a hardware logic implementation region for performing a normal function test, and a dynamic PR region including a blank mode occupying no hardware resource and a power test mode for performing a power stress test, and burning FPGA firmware having a partial reconfiguration function to a flash memory; upon receiving a request for power stress test, configuring an operation mode of the dynamic PR region to be the power test mode, loading, to the dynamic PR region, a dynamic PR configuration file burned in the flash memory; and calling a power stress test module to execute the power stress test in the dynamic PR region.

Abstract: A method and apparatus for performing a power stress test on an FPGA acceleration card and a computer-readable storage medium. The method includes: dividing, according to a partial reconfiguration method, a hardware resource of an FPGA acceleration card into a static region serving as a hardware logic implementation region for performing a normal function test, and a dynamic PR region including a blank mode occupying no hardware resources and a power test mode for performing a power stress test, and burning FPGA firmware having a partial reconfiguration function to a flash memory; upon receiving a request for power stress test, configuring an operation mode of the dynamic PR region to be the power consumption test mode, loading, to the dynamic PR region, a dynamic PR configuration file burned in the flash memory; and calling a power stress test module to execute the power stress test in the dynamic PR region.

Abstract: Disclosed are compounds suitable for enhancing cancer treatment, for example, a compound of formula (I): (I) wherein R1 is as defined herein. Also disclosed is a method of enhancing the response of cancer cells in a mammal to treatment with an apoptosis inducing ligand, a method of inducing apoptosis in cancer cells in a mammal, and a method of treating prostate cancer in mammal in need thereof comprising administration of a compound described herein.

Abstract: Receiving user input. A method includes displaying a set of characters arranged sequentially in a curvilinear or linear fashion such that any one of the characters in the set of characters can be identified for selection by continuous and uniform user input from a user. The method further comprises displaying a plurality of the characters in the set of characters in a fashion where each given character in the plurality of characters is displayed at a level of prominence determined by a probability that the given character is a next character in a string of characters selected by a user. The method further includes receiving user input in a continuous and uniform fashion from a user to identify a character in the set of characters. The method further includes receiving user input selecting the identified character. The method further includes adding the identified character to the string of characters.

Abstract: Receiving user input. A method includes displaying a set of characters arranged sequentially in a curvilinear or linear fashion such that any one of the characters in the set of characters can be identified for selection by continuous and uniform user input from a user. The method further comprises displaying a plurality of the characters in the set of characters in a fashion where each given character in the plurality of characters is displayed at a level of prominence determined by a probability that the given character is a next character in a string of characters selected by a user. The method further includes receiving user input in a continuous and uniform fashion from a user to identify a character in the set of characters. The method further includes receiving user input selecting the identified character. The method further includes adding the identified character to the string of characters.

Abstract: The present invention is directed to novel compounds and compositions that have Rsk specific inhibitory activity. In addition, inhibition of Rsk by the present compounds has been discovered to halt the proliferation of cancer cell lines while having little effect on the proliferation rate of normal cells. Therefore, the present invention identifies Rsk as a target for therapeutic intervention in diseased states in which the disease or the symptoms can be ameliorated by inhibition of Rsk catalytic activity.

Abstract: A method has been developed to extract and purify the chemical constituents in the traditional medicinal plant Salvia miltiorrhiza by an alcohol based method.